Last edition
News about "Antag Therapeutics "
Antag Therapeutics Names Dr. Joerg Moeller as its Chief Executive Officer
With over 30 years of industry and leadership experience, Dr. Moeller has an impressive track record of successfully leading large global organizations and has built an expansive portfolio by driving strategic growth, regulatory compliance, and fostering innovation.
Antag Therapeutics | 09/01/2025 | By Aishwarya
Antag Therapeutics Gets FDA Clearance IND Application for AT-7687
The study will also explore AT-7687 as a monotherapy and in combination with semaglutide, a GLP-1 receptor agonist, in healthy obese individuals.
Antag Therapeutics | 09/10/2024 | By Aishwarya
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy